On February 26, 2024, Revive Therapeutics Ltd. closed the transaction. The company issued 33,917,428 units at an issue price of CAD 0.035 for the gross proceeds of CAD 1,187,110 n its final tranche. The aggregate amount raised from the first and second closings of the offering is CAD 2,100,610. In connection with the offering, the company paid finder?s fees and issued finder warrants to Hampton Securities Limited, PI Financial Corp. and EMD Financial Inc. consisting of an aggregate of CAD 8,764.00 in cash and 250,400 warrants entitling the
holders to purchase up to an aggregate of 250,400 Units of the company.